{"entity":{"type":"insider","cik":"0001704336","url":"/insider/0001704336","json_url":"/insider/0001704336.json","name":"Cloonan Michael","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":6,"first":"2019-05-24","last":"2025-10-22","span_basis":"filed_date"},"name_variants":[{"name":"Cloonan Michael","source":"filing","n_filings":6,"first_seen":"2019-05-24","last_seen":"2025-10-22"}],"transactions":[{"id":4354858,"accession":"0001704336-25-000008","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001704336-25-000008","line_url":"/filing/0001704336-25-000008","is_derivative":false,"issuer_cik":"0001704336","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001704336","owner_cik":"0001704336","owner_name":"Cloonan Michael","owner_display_name":"Cloonan Michael","owner_url":"/insider/0001704336","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":99800.0,"shares_display":"99,800","price_per_share":36.25811973947896,"price_display":"36.26","price_state":"stated","total_value":3618560.35,"total_display":"3,618,560.35","total_whole":"3,618,560","shares_owned_after":547343.0,"shares_owned_after_display":"547,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-21","filed_date":"2025-10-22","scope":"insider","n_lines":4},{"id":4480553,"accession":"0001704336-25-000006","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001704336-25-000006","line_url":"/filing/0001704336-25-000006","is_derivative":false,"issuer_cik":"0001704336","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001704336","owner_cik":"0001704336","owner_name":"Cloonan Michael","owner_display_name":"Cloonan Michael","owner_url":"/insider/0001704336","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10425.0,"shares_display":"10,425","price_per_share":31.509905995203837,"price_display":"31.51","price_state":"stated","total_value":328490.77,"total_display":"328,490.77","total_whole":"328,491","shares_owned_after":547343.0,"shares_owned_after_display":"547,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-16","filed_date":"2025-10-17","scope":"insider","n_lines":2},{"id":4480533,"accession":"0001704336-25-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001704336-25-000006","line_url":"/filing/0001704336-25-000006#line-2","is_derivative":false,"issuer_cik":"0001704336","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001704336","owner_cik":"0001704336","owner_name":"Cloonan Michael","owner_display_name":"Cloonan Michael","owner_url":"/insider/0001704336","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14775.0,"shares_display":"14,775","price_per_share":31.1108,"price_display":"31.11","price_state":"stated","total_value":459662.07,"total_display":"459,662.07","total_whole":"459,662","shares_owned_after":547343.0,"shares_owned_after_display":"547,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-15","filed_date":"2025-10-17","scope":"insider"},{"id":4037358,"accession":"0001704336-25-000004","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001704336-25-000004","line_url":"/filing/0001704336-25-000004#line-4","is_derivative":false,"issuer_cik":"0001704336","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001704336","owner_cik":"0001704336","owner_name":"Cloonan Michael","owner_display_name":"Cloonan Michael","owner_url":"/insider/0001704336","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7793.0,"shares_display":"7,793","price_per_share":29.6999,"price_display":"29.70","price_state":"stated","total_value":231451.3207,"total_display":"231,451.32","total_whole":"231,451","shares_owned_after":547343.0,"shares_owned_after_display":"547,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-29","filed_date":"2025-09-30","scope":"insider"},{"id":4037351,"accession":"0001704336-25-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001704336-25-000004","line_url":"/filing/0001704336-25-000004#line-2","is_derivative":false,"issuer_cik":"0001704336","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001704336","owner_cik":"0001704336","owner_name":"Cloonan Michael","owner_display_name":"Cloonan Michael","owner_url":"/insider/0001704336","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17207.0,"shares_display":"17,207","price_per_share":28.8456,"price_display":"28.85","price_state":"stated","total_value":496346.2392,"total_display":"496,346.24","total_whole":"496,346","shares_owned_after":547343.0,"shares_owned_after_display":"547,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-26","filed_date":"2025-09-30","scope":"insider"},{"id":5223004,"accession":"0002036042-25-000051","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0002036042-25-000051","line_url":"/filing/0002036042-25-000051#line-4","is_derivative":false,"issuer_cik":"0001704336","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001704336","owner_cik":"0001704336","owner_name":"Cloonan Michael","owner_display_name":"Cloonan Michael","owner_url":"/insider/0001704336","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7426.0,"shares_display":"7,426","price_per_share":25.0086,"price_display":"25.01","price_state":"stated","total_value":185713.8636,"total_display":"185,713.86","total_whole":"185,714","shares_owned_after":547343.0,"shares_owned_after_display":"547,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-27","filed_date":"2025-08-28","scope":"insider"},{"id":5222995,"accession":"0002036042-25-000051","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0002036042-25-000051","line_url":"/filing/0002036042-25-000051#line-2","is_derivative":false,"issuer_cik":"0001704336","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001704336","owner_cik":"0001704336","owner_name":"Cloonan Michael","owner_display_name":"Cloonan Michael","owner_url":"/insider/0001704336","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17574.0,"shares_display":"17,574","price_per_share":24.96,"price_display":"24.96","price_state":"stated","total_value":438647.04,"total_display":"438,647.04","total_whole":"438,647","shares_owned_after":547343.0,"shares_owned_after_display":"547,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-26","filed_date":"2025-08-28","scope":"insider"},{"id":4782914,"accession":"0001482981-25-000144","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001482981-25-000144","line_url":"/filing/0001482981-25-000144#line-2","is_derivative":false,"issuer_cik":"0001704336","issuer_name":"Sionna Therapeutics, Inc.","issuer_ticker":"SION","issuer_name_source":null,"issuer_url":"/issuer/0001704336","owner_cik":"0001704336","owner_name":"Cloonan Michael","owner_display_name":"Cloonan Michael","owner_url":"/insider/0001704336","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":22.75,"price_display":"22.75","price_state":"stated","total_value":568750.0,"total_display":"568,750.00","total_whole":"568,750","shares_owned_after":547343.0,"shares_owned_after_display":"547,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-20","filed_date":"2025-08-21","scope":"insider"},{"id":8370957,"accession":"0001562180-19-003095","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-19-003095","line_url":"/filing/0001562180-19-003095#line-2","is_derivative":false,"issuer_cik":"0001597553","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001597553","owner_cik":"0001704336","owner_name":"Cloonan Michael","owner_display_name":"Cloonan Michael","owner_url":"/insider/0001704336","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":175.0,"price_display":"175.00","price_state":"stated","total_value":4375000.0,"total_display":"4,375,000.00","total_whole":"4,375,000","shares_owned_after":461.0,"shares_owned_after_display":"461","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-22","filed_date":"2019-05-24","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0002036042","name":"Sionna Therapeutics, Inc.","url":"/issuer/0002036042","role":"Director, Officer (President & CEO)","n_filings":5,"first_seen":"2025-08-21","last_seen":"2025-10-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001597553","name":"Sage Therapeutics, Inc.","url":"/issuer/0001597553","role":"Officer (Chief Business Officer)","n_filings":1,"first_seen":"2019-05-24","last_seen":"2019-05-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001704336","retrieved_at":"2026-08-26T13:04:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}